Body Composition Measurements in Pneumonia

Acute Infection Respiratory Clinical Trial

Official title:

Body Composition in Patients With Acute Pneumonia Measured by Bioimpedance and DXA

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04223453
• Other study ID #: Daniel1
• Status: Completed
• Start date: January 5, 2019
• Est. completion date: September 30, 2019

Study information

• Verified date: January 2020
• Source: University of Copenhagen
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to validate and standardize bioelectrical impedance analysis (BIA, Maltron BioScan touch i8) for estimating body composition in hospitalized elderly patients with pneumonia. Body composition assessments with BIA and dual-energy x-ray absorptiometry (DXA,

Description:

Holigic Discovery) was performed on 36 non-fasting patients over 65 years of age. 29 patients had BIA performed within 24 hours after hospital admission and at the date of discharge. 17 patients had BIA performed in fasted state and one hour after an intake of 300 ml glucose solution.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 36
• Est. completion date: September 30, 2019
• Est. primary completion date: July 17, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Acute pneumonia,

• Accept participation (informed consent)

• Understand the given instructions and information

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Acute Infection Respiratory
• Pneumonia
• Respiratory Tract Infections

Intervention

Diagnostic Test:
• BIA and DXA
Patients with acute pneumonia measured simultaneously with DXA-scan and BIA-impedance

Locations

Country	Name	City	State
Denmark	Hillerød Hospital	Hillerød

Sponsors (2)

Lead Sponsor	Collaborator
Jens Rikardt Andersen	Hillerod Hospital, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Correlation between LBM (lean body mass) with DXA and BIA	At admittance both methods.	within 3 days
Secondary	Development in lean-body-mass during hospital stay	Repeated measurement with BIA during the state of acute infection	3-10 days (hospital stay)
Secondary	BIA measured before and after oral glucose load test	To investigate for the effect of fasting on the determination of total body water with BIA	1 hour